The Tenon Medical Mission:

Richard Ferrari is a Tenon Founder, Director, and Executive Chairman of the Company. Since 2000, Mr. Ferrari has been Managing Director of Denovo Ventures, specializing in Medical Devices and Biotechnology. Mr. Ferrari previously served as CEO and Chairman of the Board of Directors of PQ Bypass, which culminated in a successful acquisition by Endologix. Mr. Ferrari is Executive Chairman of the Board for Medlumics, S.L.; Vice Chairman of the Board for ABS Interventional; Executive Chairman of the Board for Heart Beam Inc.; a board member of Biomodex Corporation, Retriever Medical Inc., RMx Medical, Hawthorne Effect, Inc., and Hands of Hope; board member and co-founder of TransAortic (acquired by Medtronic); Executive Chairman of Sentreheart (acquired by Atricure), board member of Spinal Modualtion (acquired by St Jude). Mr. Ferrari has raised over $1Billion for the companies he has been involved with and has been a key member of M&A teams, achieving over $2Billion in acquisitions. Mr. Ferrari is a mentor and advisor to CEOs and start-up companies on strategy and building organizations dedicated to delivering excellence. Mr. Ferrari is the creator of Excellence by Choice, a series of lectures and presentations to help early-stage companies perform at the highest level of execution. Mr. Ferrari received a Bachelor’s Degree in Education from Ashland University and an MBA from University of South Florida.

Steven M. Foster serves as Chief Executive Officer & President and is also a Director of the Company. Mr. Foster has over 30 years of marketing, sales, operations, and general management experience in the medical device industry. Most recently, Mr. Foster was the principal with CTB Advisors, LLC, providing medical device organizations with consultative assistance on commercialization-focused projects. Clients included NuVasive (NUVA), SafeOp Surgical, and Alphatec Spine (ATEC).

Mr. Foster was Global Commercialization President of Safe Orthopaedics SAS; VP/GM of Medtronic Spine’s Western Europe operations, and held a progressive succession of sales, marketing, and general management roles in the Danek Group Inc., Sofamor Danek, Medtronic Spine & Biologics organization. Mr. Foster started his career in a variety of operational roles with Stryker Endoscopy (SYK). Mr. Foster received a Bachelor of Science, Business Administration with a concentration in Marketing and Management and Logistics from Central Michigan University.

Richard Ginn is a founder of Tenon Medical and is the Chief Technology Officer and a Director of the company, with a focus on intellectual property and product development. Mr. Ginn has travelled globally to train physicians and participate in FIH trials. He is a named inventor on more than 300 patents for medical devices. Mr. Ginn has helped raise more than $100 million in venture capital. In 2013, Mr. Ginn founded TransAortic Medical, an embolic protection device company, and is the President, CEO and a director. At TransAortic, Mr. Ginn managed all corporate operations, raised capital to support company needs; managed acquisition of technology by strategic partner; managed all Intellectual Property; and set up European distribution for a CE Marked device. Mr. Ginn is the founder of Promed, a large hole femoral closure device company, where he was the CEO, President and a director.

Nate Grawey serves as Chief Commercial Officer for the Company. He is a seasoned medical device executive who has built his career at the intersection of innovation and execution. Nate has led the commercialization of technologies in surgical navigation, robotics, and implant systems, consistently helping companies bring complex ideas to market in ways that create value for both physicians and patients.

Nate has worked closely with physicians, investors, and emerging healthcare companies to shape strategies that translate into real-world growth. As an entrepreneur, he has founded several ventures in the medical device space, having firsthand insight from concept through commercialization and exit. He is recognized for assembling strong, high-performing teams and fostering relationships that drive collaboration across clinical and business stakeholders.

Before joining the Company, Nate held commercial leadership roles at Medtronic and Accelus Inc. He holds a degree in Aeronautics and an MBA.

Wyatt Giest serves as Chief Innovation Officer for the Company. A background in Microbiology, Biochemistry & Engineering, Wyatt Geist is a forward-thinking inventor and business leader with a passion for transforming groundbreaking concepts into real-world solutions. As a seasoned entrepreneur, Wyatt has successfully navigated company formation, capital raising, product development, marketing, and sales team formation—leading multiple ventures from inception to acquisition.

With over 190 patent submissions and numerous industry awards for innovation, his expertise spans transportation, medical solutions, and emerging technologies. Wyatt's ability to cultivate company culture, build high-performing teams, and drive strategic growth has resulted in multiple successful exits to Fortune 500 companies.

Kevin Williamson is Tenon Medical's Chief Financial Officer. Mr. Williamson most recently served as the Chief Financial Officer at Accelus Inc., a medical device company focused on expandable spinal implant technology. In this role, Mr. Williamson was responsible for the finance organization, in addition to the investor relations and IT functions. From 2019 to 2020, Mr. Williamson served in the Director of Finance position at Accelus Inc., where he was responsible for Financial Planning and Analysis. From 2015 to 2019, Mr. Williamson held various roles of increasing responsibility in the Corporate Finance department at NuVasive, Inc., a California-based medical device company focused on minimally invasive spine surgery. Mr. Williamson holds a B.S. in Business Administration, Finance from San Diego State University and an M.B.A. from the University of San Diego Knauss School of Business.

Steve Moscaret serves as General Manager, Marketing and Sales Operation for the Company. Mr. Moscaret has over thirty-five years of successful sales and marketing experience and management in the medical device industry in both Fortune 500 corporations as well as early, mid and late-stage venture backed start-ups. Prior to Tenon Medical, Mr. Moscaret served as Vice President, Global Marketing at Intersect ENT (Nasdaq: XENT) and was responsible for all global marketing functions at the company. Mr. Moscaret was also Vice President of Marketing at Spinal Kinetics where he led the marketing branding and launch of the Company’s M6 Artificial Disc in both the domestic and international spine markets. He joined Orthofix Medical (Nasdaq OFIX) upon its acquisition of Spinal Kinetics and helped successfully integrate the M6 technology into the Company’s spine division. Mr. Moscaret has also held various sales and marketing leadership positions throughout his career at Boston Scientific, Asthmatx, LuMend, Guidant and J&J Ethicon Endo-Surgery.

Stephen H. Hochschuler, M.D. is a world-renowned orthopedic spine surgeon. Dr. Hochschuler is the co-founder of the Texas Back Institute, founder of Back Systems, Inc., and founding Chairman of Innovative Spinal Technologies. Dr. Hochschuler has served on numerous boards of directors and advisory boards for medical and scientific institutions. Dr. Hochschuler is a member of numerous national and international professional organizations including the American Academy of Orthopedic Surgeons; the American Pain Society; North American Spine Society; and the Southwest Chapter of the Society of International Business Fellows. Internationally, he is a member of the International Intradiscal Therapy Society; the International Society for Minimal Intervention in Spinal Surgery; the International Society for the Study of the Lumbar Spine; and is a founding board member of the Spinal Arthroplasty Society. He has also been a founding board member of The American Board of Spine Surgery and The American College of Spine Surgery. He is published in a wide range of professional journals and has delivered numerous presentations worldwide. Dr. Hochschuler holds a BA from Columbia College and his medical degree from Harvard Medical School.

Mr. Howard is an Executive Director in Alternative Investments in Banco Santander International's Private Banking division based in Miami, FL. Mr. Howard is responsible for sourcing, due diligence, and investment in hedge funds and alternative fund managers for Santander's offshore private banking clients. Mr. Howard joined Santander with 20 years of experience in investment management, portfolio construction, and alternative investment fund structuring. Previously Mr. Howard was an Outsourced Chief Investment Officer with Hirtle Callaghan providing portfolio construction and investment management services to endowments, foundations, and family offices. Prior to Hirtle Callaghan, Mr. Howard was Managing Director of Alternative Investments with The GreenHaven Group specializing in the creation of public and private, real estate and alternative investment strategies. Mr. Howard was also formerly a Director of Equity Sales and Trading with Merrill Lynch responsible for providing portfolio liquidity solutions to institutional clients. Mr. Howard holds a master's degree in Polymer Science Engineering from the University of Florida and an MBA from Mercer University. Mr. Howard serves on the external advisory board for the University of Florida College of Biomedical Engineering.

Robert K. Weigle is the CEO of Prime Genomics, a saliva-based diagnostics company utilizing Genomics. Mr. Weigle is also currently an executive in residence with DigitalDX, a venture capital firm. Mr. Weigle was formerly CEO and a director of Benvenue Medical, leading a commercial launch of first-generation devices in two distinct markets, treatment of compression fractures in the spine and treatment of degenerative disc disease. Mr. Weigle oversaw all early aspects of corporate strategy, including defining, communicating and executing the company’s overall business model, and represented Benvenue to the investment community. Mr. Weigle was also a senior executive at numerous healthcare and medical device companies including TherOx, Inc, Cardiac Pathways, Baxter Healthcare and Cardima Corporation. Mr. Weigle also has relevant experience at Johnson & Johnson. Mr. Weigle holds a BA in Political Science from University of California, Berkeley.

Kristen Jacques brings over 35 years of experience in various executive leadership roles in the medical devices field with expertise in global commercialization, marketing, and product management. Most recently, Ms. Jacques was Vice President & GM, Interventional Pain Therapies of Vivex Biologics, Inc. where she leveraged her experience in global commercialization to spearhead the go-to-market strategy of disruptive technology in the interventional spine market. Before her tenure at Vivex, Ms. Jacques served in multiple senior management roles at publicly traded Alphatec Spine, Inc. (ATEC), General Electric Corporation (GE) and Smith and Nephew, PLC (SNN). Ms. Jacques received a Bachelor of Arts degree in Finance Administration from Michigan State University.